A new trading day began on November 20, 2023, with Replimune Group Inc (NASDAQ: REPL) stock priced at $10.22, down -2.12% from the previous day of trading. During the day, the shares moved up to $10.5562 and dropped to $9.79 before settling in for the closing price of $10.40. REPL’s price has ranged from $10.25 to $29.52 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -16.64%. With a float of $43.38 million, this company’s outstanding shares have now reached $56.68 million.
In an organization with 284 employees, it is important to assess its efficiency.
Replimune Group Inc (REPL) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Replimune Group Inc is 26.55%, while institutional ownership is 86.53%. The most recent insider transaction that took place on Nov 16, was worth 79,858. In this transaction Chief Medical Officer of this company sold 7,313 shares at a rate of $10.92, taking the stock ownership to the 112,714 shares. Before that another transaction happened on Nov 16, when Company’s Chief Commercial Officer sold 5,255 for $10.92, making the entire transaction worth $57,385. This insider now owns 72,245 shares in total.
Replimune Group Inc (REPL) Performance Highlights and Predictions
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.9 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -36.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.93 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.64% per share during the next fiscal year.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Here are Replimune Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.20, a number that is poised to hit -0.88 in the next quarter and is forecasted to reach -3.70 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Let’s dig in a bit further. During the last 5-days, its volume was 1.95 million. That was better than the volume of 0.62 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.54%. Additionally, its Average True Range was 1.05.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 2.79%, which indicates a significant decrease from 7.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.07% in the past 14 days, which was higher than the 60.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.69, while its 200-day Moving Average is $18.95. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $10.56. Second resistance stands at $10.94. The third major resistance level sits at $11.33. If the price goes on to break the first support level at $9.79, it is likely to go to the next support level at $9.41. Assuming the price breaks the second support level, the third support level stands at $9.03.
Replimune Group Inc (NASDAQ: REPL) Key Stats
With a market capitalization of 601.23 million, the company has a total of 59,059K Shares Outstanding. Currently, annual sales are 0 K while annual income is -174,280 K. The company’s previous quarter sales were 0 K while its latest quarter income was -60,040 K.